{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:23:15Z","timestamp":1792790595044,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11895-2","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:15:52Z","timestamp":1761902152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Disseminated Mycobacterium avium and Talaromyces Marneffei coinfection in a patient of misdiagnosed tuberculosis and the challenges: a case report"],"prefix":"10.1186","volume":"25","author":[{"given":"Hui-Hui","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Lei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Fa","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"11895_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijid.2022.10.013","volume":"125","author":"VN Dahl","year":"2022","unstructured":"Dahl VN, Molhave M, Floe A, van Ingen J, Schon T, Lillebaek T, et al. Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. Int J Infect Dis. 2022;125:120\u201331. https:\/\/doi.org\/10.1016\/j.ijid.2022.10.013.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"11895_CR2","doi-asserted-by":"publisher","first-page":"e48270","DOI":"10.7759\/cureus.48270","volume":"15","author":"J Bhanushali","year":"2023","unstructured":"Bhanushali J, Jadhav U, Ghewade B. Wagh. Unveiling the clinical diversity in nontuberculous mycobacteria (NTM) infections: A comprehensive review. Cureus. 2023;15(11):e48270. https:\/\/doi.org\/10.7759\/cureus.48270.","journal-title":"Cureus"},{"issue":"3","key":"11895_CR3","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3201\/eid1703.101164","volume":"17","author":"BA Kendall","year":"2011","unstructured":"Kendall BA, Varley CD, Choi D, Cassidy PM, Hedberg K, Ware MA, et al. Distinguishing tuberculosis from nontuberculous mycobacteria lung disease, Oregon, USA. Emerg Infect Dis. 2011;17(3):506\u20139. https:\/\/doi.org\/10.3201\/eid1703.101164.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"11895_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41573-024-00897-5","volume":"23","author":"V Dartois","year":"2024","unstructured":"Dartois V, Dick T. Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease. Nat Rev Drug Discov. 2024;23(5):381\u2013403. https:\/\/doi.org\/10.1038\/s41573-024-00897-5.","journal-title":"Nat Rev Drug Discov"},{"key":"11895_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2217\/fmb-2021-0016","volume":"16","author":"R Mattoo","year":"2021","unstructured":"Mattoo R. Targeting emerging Mycobacterium avium infections: perspectives into pathways and antimicrobials for future interventions. Future Microbiol. 2021;16:753\u201364. https:\/\/doi.org\/10.2217\/fmb-2021-0016.","journal-title":"Future Microbiol"},{"issue":"1","key":"11895_CR6","doi-asserted-by":"publisher","first-page":"e0005122","DOI":"10.1128\/cmr.00051-22","volume":"36","author":"F Wang","year":"2023","unstructured":"Wang F, Han R, Chen S. An overlooked and underrated endemic Mycosis-Talaromycosis and the pathogenic fungus talaromyces Marneffei. Clin Microbiol Rev. 2023;36(1):e0005122. https:\/\/doi.org\/10.1128\/cmr.00051-22.","journal-title":"Clin Microbiol Rev"},{"key":"11895_CR7","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.2147\/IDR.S218836","volume":"12","author":"SS Su","year":"2019","unstructured":"Su SS, Zhang SN, Ye JR, Xu LN, Lin PC, Xu HY, et al. Disseminated talaromyces Marneffei and Mycobacterium avium infection accompanied sweet\u2019s syndrome in A patient with Anti-Interferon-gamma autoantibodies: A case report. Infect Drug Resist. 2019;12:3189\u201395. https:\/\/doi.org\/10.2147\/IDR.S218836.","journal-title":"Infect Drug Resist"},{"issue":"9","key":"11895_CR8","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.medcli.2020.12.026","volume":"157","author":"G Yu","year":"2021","unstructured":"Yu G, Xu X, Ye B. Disseminated Mycobacterium avium and talaromyces Marneffei coinfection. Med Clin (Barc). 2021;157(9):458. https:\/\/doi.org\/10.1016\/j.medcli.2020.12.026.","journal-title":"Med Clin (Barc)"},{"issue":"7","key":"11895_CR9","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1128\/CVI.00053-10","volume":"17","author":"BS Tang","year":"2010","unstructured":"Tang BS, Chan JF, Chen M, Tsang OT, Mok MY, Lai RW, et al. Disseminated penicilliosis, recurrent bacteremic nontyphoidal salmonellosis, and burkholderiosis associated with acquired immunodeficiency due to autoantibody against gamma interferon. Clin Vaccine Immunol. 2010;17(7):1132\u20138. https:\/\/doi.org\/10.1128\/CVI.00053-10.","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"11895_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijtb.2024.08.006","volume":"72","author":"LT Ong","year":"2025","unstructured":"Ong LT. Epidemiology of nontuberculous mycobacteria infection in asia: A narrative review. Indian J Tuberc. 2025;72(2):259\u201365. https:\/\/doi.org\/10.1016\/j.ijtb.2024.08.006.","journal-title":"Indian J Tuberc"},{"issue":"11","key":"11895_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/17476348.2023.2283135","volume":"17","author":"KA Hamed","year":"2023","unstructured":"Hamed KA, Tillotson G. A narrative review of nontuberculous mycobacterial pulmonary disease: microbiology, epidemiology, diagnosis, and management challenges. Expert Rev Respir Med. 2023;17(11):973\u201388. https:\/\/doi.org\/10.1080\/17476348.2023.2283135.","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"11895_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-020-00667-6","volume":"27","author":"R Gopalaswamy","year":"2020","unstructured":"Gopalaswamy R, Shanmugam S, Mondal R, Subbian S. Of tuberculosis and non-tuberculous mycobacterial infections - a comparative analysis of epidemiology, diagnosis and treatment. J Biomed Sci. 2020;27(1):74. https:\/\/doi.org\/10.1186\/s12929-020-00667-6.","journal-title":"J Biomed Sci"},{"issue":"1","key":"11895_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12879-018-3113-x","volume":"18","author":"R Diel","year":"2018","unstructured":"Diel R, Lipman M, Hoefsloot W. High mortality in patients with Mycobacterium avium complex lung disease: a systematic review. BMC Infect Dis. 2018;18(1):206. https:\/\/doi.org\/10.1186\/s12879-018-3113-x.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11895_CR14","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1038\/s41598-023-34576-z","volume":"13","author":"H Hwang","year":"2023","unstructured":"Hwang H, Lee JK, Heo EY, Kim DK, Lee HW. The factors associated with mortality and progressive disease of nontuberculous mycobacterial lung disease: a systematic review and meta-analysis. Sci Rep. 2023;13(1):7348. https:\/\/doi.org\/10.1038\/s41598-023-34576-z.","journal-title":"Sci Rep"},{"issue":"7","key":"11895_CR15","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1016\/S1473-3099(21)00586-7","volume":"22","author":"C Lange","year":"2022","unstructured":"Lange C, Bottger EC, Cambau E, Griffith DE, Guglielmetti L, van Ingen J, et al. Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. Lancet Infect Dis. 2022;22(7):e178\u201390. https:\/\/doi.org\/10.1016\/S1473-3099(21)00586-7.","journal-title":"Lancet Infect Dis"},{"key":"11895_CR16","doi-asserted-by":"publisher","first-page":"100244","DOI":"10.1016\/j.jctube.2021.100244","volume":"24","author":"KM Pennington","year":"2021","unstructured":"Pennington KM, Vu A, Challener D, Rivera CG, Shweta FNU, Zeuli JD, et al. Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease. J Clin Tuberc Other Mycobact Dis. 2021;24:100244. https:\/\/doi.org\/10.1016\/j.jctube.2021.100244.","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"11895_CR17","doi-asserted-by":"publisher","unstructured":"Lyon SM, Rossman MD. Pulmonary tuberculosis. Microbiol Spectr. 2017;5(1). https:\/\/doi.org\/10.1128\/microbiolspec.tnmi7-0032-2016.","DOI":"10.1128\/microbiolspec.tnmi7-0032-2016"},{"issue":"4","key":"11895_CR18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","volume":"71","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin Infect Dis. 2020;71(4):905\u201313. https:\/\/doi.org\/10.1093\/cid\/ciaa1125.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"11895_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1055\/s-0033-1333569","volume":"34","author":"J van Ingen","year":"2013","unstructured":"van Ingen J. Diagnosis of nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013;34(1):103\u20139. https:\/\/doi.org\/10.1055\/s-0033-1333569.","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"11895_CR20","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1007\/s11033-020-05413-7","volume":"47","author":"B Acharya","year":"2020","unstructured":"Acharya B, Acharya A, Gautam S, Ghimire SP, Mishra G, Parajuli N, et al. Advances in diagnosis of tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis. Mol Biol Rep. 2020;47(5):4065\u201375. https:\/\/doi.org\/10.1007\/s11033-020-05413-7.","journal-title":"Mol Biol Rep"},{"issue":"11","key":"11895_CR21","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/antibiotics9110771","volume":"9","author":"I Joao","year":"2020","unstructured":"Joao I, Bujdakova H, Jordao L. Opportunist coinfections by nontuberculous mycobacteria and fungi in immunocompromised patients. Antibiot (Basel). 2020;9(11):771. https:\/\/doi.org\/10.3390\/antibiotics9110771.","journal-title":"Antibiot (Basel)"},{"issue":"11","key":"11895_CR22","doi-asserted-by":"publisher","first-page":"e0188716","DOI":"10.1371\/journal.pone.0188716","volume":"12","author":"BW Jhun","year":"2017","unstructured":"Jhun BW, Jung WJ, Hwang NY, Park HY, Jeon K, Kang ES, et al. Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease. PLoS ONE. 2017;12(11):e0188716. https:\/\/doi.org\/10.1371\/journal.pone.0188716.","journal-title":"PLoS ONE"},{"issue":"1","key":"11895_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10096-017-3105-6","volume":"37","author":"K Furuuchi","year":"2018","unstructured":"Furuuchi K, Ito A, Hashimoto T, Kumagai S, Ishida T. Clinical significance of Aspergillus species isolated from respiratory specimens in patients with Mycobacterium avium complex lung disease. Eur J Clin Microbiol Infect Dis. 2018;37(1):91\u20138. https:\/\/doi.org\/10.1007\/s10096-017-3105-6.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"11895_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.idcr.2018.02.013","volume":"12","author":"MT Castro-Lainez","year":"2018","unstructured":"Castro-Lainez MT, Sierra-Hoffman M, L.-Z. L, J R, Adams A, Howell H, Hoffman-Roberts, et al. Talaromyces Marneffei infection in a non-HIV non-endemic population. IDCases. 2018;12:21\u20134. https:\/\/doi.org\/10.1016\/j.idcr.2018.02.013.","journal-title":"IDCases"},{"issue":"1","key":"11895_CR25","doi-asserted-by":"publisher","first-page":"16177","DOI":"10.1038\/s41598-021-95686-0","volume":"11","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Huang J, Li Y, Zeng W, Pan M, Cen J, et al. Talaromyces Marneffei and nontuberculous mycobacteria co-infection in HIV-negative patients. Sci Rep. 2021;11(1):16177. https:\/\/doi.org\/10.1038\/s41598-021-95686-0.","journal-title":"Sci Rep"},{"key":"11895_CR26","doi-asserted-by":"publisher","first-page":"1579522","DOI":"10.3389\/fmed.2025.1579522","volume":"12","author":"A Wu","year":"2025","unstructured":"Wu A, Gai W, Guo Y, Zhou C, Xu Y, Zhang X, et al. Clinical features of talaromyces Marneffei infection and colonization in HIV-negative patients: the role of mNGS in diagnosis. Front Med (Lausanne). 2025;12:1579522. https:\/\/doi.org\/10.3389\/fmed.2025.1579522.","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"11895_CR27","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/myc.13295","volume":"64","author":"L He","year":"2021","unstructured":"He L, Mei X, Lu S, Ma J, Hu Y, Mo D, et al. Talaromyces Marneffei infection in non-HIV-infected patients in Mainland China. Mycoses. 2021;64(10):1170\u20136. https:\/\/doi.org\/10.1111\/myc.13295.","journal-title":"Mycoses"},{"key":"11895_CR28","doi-asserted-by":"publisher","unstructured":"Yang ZM, Huang J, Chen XM, Meng X, Qiu Y, Zeng W et al. [Advances in clinical characteristics of talaromycosis combined with other opportunistic infections]. Zhonghua Jie He He Hu Xi Za Zhi. 2023; 46(5): 503\u2013506. Chinese. https:\/\/doi.org\/10.3760\/cma.j.cn112147-20220807-00659","DOI":"10.3760\/cma.j.cn112147-20220807-00659"},{"issue":"1","key":"11895_CR29","doi-asserted-by":"publisher","first-page":"9069","DOI":"10.1038\/s41598-022-13160-x","volume":"12","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Tang M, Zeng W, Feng X, Pan M, Li W, et al. Clinical findings and predictive factors for positive anti-interferon-gamma autoantibodies in patients suffering from a non-tuberculosis mycobacteria or talaromyces Marneffei infection: a multicenter prospective cohort study. Sci Rep. 2022;12(1):9069. https:\/\/doi.org\/10.1038\/s41598-022-13160-x.","journal-title":"Sci Rep"},{"issue":"1","key":"11895_CR30","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jmii.2023.11.006","volume":"57","author":"PH Wang","year":"2024","unstructured":"Wang PH, Shu CC, Chen CY, Wei YF, Cheng SL. The role of treatment regimen and duration in treating patients with Mycobacterium avium complex lung disease: A real-world experience and case-control study. J Microbiol Immunol Infect. 2024;57(1):164\u201374. https:\/\/doi.org\/10.1016\/j.jmii.2023.11.006.","journal-title":"J Microbiol Immunol Infect"},{"issue":"24","key":"11895_CR31","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1056\/NEJMoa1613306","volume":"376","author":"T Le","year":"2017","unstructured":"Le T, Kinh NV, Cuc NTK, Tung NLN, Lam NT, Thuy PTT, et al. A trial of Itraconazole or amphotericin B for HIV-Associated talaromycosis. N Engl J Med. 2017;376(24):2329\u201340. https:\/\/doi.org\/10.1056\/NEJMoa1613306.","journal-title":"N Engl J Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11895-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11895-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:15:54Z","timestamp":1761902154000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11895-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11895"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11895-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4814788\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"28 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was conducted in accordance with the Declaration of Helsinki. It was approved by the Ethics Committee of the First Affiliated Hospital of Gannan Medical University (No: LLSL-2023171).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Both the patient and her father gave written and oral informed consent to publish the clinical details and images. The consent form was obtained from the hospital during the patient\u2019s inpatient stay.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1458"}}